- Home
- DYAI vs IINN Comparison
DYAI vs IINN Comparison
Compare DYAI & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYAI | IINN |
|---|---|---|
| Founded | 1979 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 35.3M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | DYAI | IINN |
|---|---|---|
| Price | $0.76 | $0.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.00 | $2.00 |
| AVG Volume (30 Days) | 76.9K | ★ 300.8K |
| Earning Date | 05-13-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,090,345.00 | N/A |
| Revenue This Year | $122.79 | $16,841.18 |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.65 | $0.34 |
| 52 Week High | $1.35 | $1.65 |
Technical Indicators
Market Signals| Indicator | DYAI | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 35.89 |
| Support Level | $0.74 | $0.34 |
| Resistance Level | $0.98 | $0.63 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 65.38 | 15.80 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.